Yunqing Qiu

12.2k total citations · 4 hit papers
97 papers, 6.1k citations indexed

About

Yunqing Qiu is a scholar working on Molecular Biology, Infectious Diseases and Cancer Research. According to data from OpenAlex, Yunqing Qiu has authored 97 papers receiving a total of 6.1k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Molecular Biology, 24 papers in Infectious Diseases and 21 papers in Cancer Research. Recurrent topics in Yunqing Qiu's work include SARS-CoV-2 and COVID-19 Research (12 papers), COVID-19 Clinical Research Studies (12 papers) and MicroRNA in disease regulation (9 papers). Yunqing Qiu is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (12 papers), COVID-19 Clinical Research Studies (12 papers) and MicroRNA in disease regulation (9 papers). Yunqing Qiu collaborates with scholars based in China, United States and Singapore. Yunqing Qiu's co-authors include Feng Zhu, Yan Lou, Kaijin Xu, Lanjuan Li, Jifang Sheng, Hongliu Cai, Fengcheng Li, Xiaowei Xu, Xiaoxin Wu and Hainv Gao and has published in prestigious journals such as Nucleic Acids Research, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Yunqing Qiu

95 papers receiving 6.0k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series

2020 1.5k citations Xiaowei Xu, Xiaoxin Wu et al. BMJ profile →
Targeting photodynamic and photothermal therapy to the endoplasmic reticulum enhances immunogenic cancer cell death

2019 939 citations Yan Lou, Yunqing Qiu et al. Nature Communications profile →
Therapeutic target database update 2022: facilitating drug discovery with enriched comparative data of targeted agents

2021 417 citations Ying Zhou, Yintao Zhang et al. Nucleic Acids Research profile →
TTD: Therapeutic Target Database describing target druggability information

2023 289 citations Ying Zhou, Yintao Zhang et al. Nucleic Acids Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yunqing Qiu China	30	2.1k	1.9k	954	833	664	97	6.1k
Hong Shan China	33	1.9k 0.9×	3.6k 1.9×	863 0.9×	1.5k 1.8×	1.2k 1.8×	93	8.5k
Yushun Wan China	18	2.2k 1.1×	6.9k 3.7×	267 0.3×	1.4k 1.7×	566 0.9×	30	9.3k
Qiwei Zhang China	35	1.5k 0.7×	2.4k 1.3×	248 0.3×	549 0.7×	440 0.7×	203	5.9k
Jian Shang China	19	2.1k 1.0×	7.5k 4.0×	288 0.3×	1.5k 1.8×	553 0.8×	58	9.7k
Wu Zhong China	27	1.4k 0.7×	2.5k 1.3×	229 0.2×	535 0.6×	384 0.6×	116	5.4k
Rong Xu United States	43	2.3k 1.1×	898 0.5×	140 0.1×	705 0.8×	761 1.1×	234	6.8k
Zhao Su China	6	1.7k 0.8×	5.5k 2.9×	518 0.5×	918 1.1×	518 0.8×	10	7.9k
Asher Mullard Canada	53	4.9k 2.3×	623 0.3×	656 0.7×	250 0.3×	2.1k 3.2×	604	9.9k
Jindřich Činátl Germany	59	4.9k 2.4×	3.2k 1.7×	585 0.6×	1.0k 1.3×	2.0k 3.0×	352	13.4k
Hongxia Liu China	23	1.4k 0.7×	4.4k 2.4×	236 0.2×	2.4k 2.9×	824 1.2×	84	7.6k

Countries citing papers authored by Yunqing Qiu

Since Specialization

Citations

This map shows the geographic impact of Yunqing Qiu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yunqing Qiu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yunqing Qiu more than expected).

Fields of papers citing papers by Yunqing Qiu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yunqing Qiu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yunqing Qiu. The network helps show where Yunqing Qiu may publish in the future.

Co-authorship network of co-authors of Yunqing Qiu

This figure shows the co-authorship network connecting the top 25 collaborators of Yunqing Qiu. A scholar is included among the top collaborators of Yunqing Qiu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yunqing Qiu. Yunqing Qiu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lou, Yan, Yu Wang, Jing Liu, et al.. (2025). Voriconazole-induced liver injury: incidence patterns and risk factors in a retrospective cohort. Antimicrobial Agents and Chemotherapy. 69(9). e0048725–e0048725.

Liu, Yi, et al.. (2025). NAE1 protein: a prognostic, immunomodulatory, and therapeutic biomarker associated with neddylation in hepatocellular carcinoma. International Journal of Biological Macromolecules. 310(Pt 4). 143539–143539. 1 indexed citations

Zhang, Yintao, Yinghong Li, Jianbo Fu, et al.. (2025). Dynamic clinical trial success rates for drugs in the 21st century. Nature Communications. 16(1). 9537–9537. 1 indexed citations

Zhao, Qingwei, et al.. (2024). Safety, tolerability and pharmacokinetics of ASC10, a novel oral double prodrug of a broad-spectrum antiviral agent, β-d-N4-hydroxycytidine: results from a randomized, double-blind, placebo-controlled phase 1 study in Chinese healthy subjects. Expert Opinion on Investigational Drugs. 33(8). 867–876. 1 indexed citations

Liu, Jing, et al.. (2024). Identification of molecular subtypes based on bile acid metabolism in cholangiocarcinoma. BMC Cancer. 24(1). 1313–1313. 5 indexed citations

Yang, Xiuyan, Lu Han, Xi Yang, et al.. (2024). Optimizing the dosing regimen of roxadustat in kidney transplant recipients with early post-transplant anemia. Journal of Pharmaceutical Sciences. 113(11). 3344–3353. 1 indexed citations

Lin, Meihua, et al.. (2023). Effect of Food on the Pharmacokinetics of Tenofovir Amibufenamide: A Phase I, Randomized, Open-Label, Two-Period Crossover Trial in Healthy Adult Subjects. Drug Design Development and Therapy. Volume 17. 3061–3072. 2 indexed citations

Jin, Xuehang, et al.. (2023). Serum Ribonucleotide Reductase Subunit M2 in Patients with Chronic Liver Diseases and Hepatocellular Carcinoma. Laboratory Medicine. 54(6). 626–632. 2 indexed citations

Zhang, Yintao, Ying Zhou, Yuan Zhou, et al.. (2023). TheMarker: a comprehensive database of therapeutic biomarkers. Nucleic Acids Research. 52(D1). D1450–D1464. 40 indexed citations

10.

Zhou, Ying, Yintao Zhang, Donghai Zhao, et al.. (2023). TTD: Therapeutic Target Database describing target druggability information. Nucleic Acids Research. 52(D1). D1465–D1477. 289 indexed citations breakdown →

11.

He, Xiaoying, Jiali Wang, Qian Wang, et al.. (2022). P38 MAPK, NF-κB, and JAK-STAT3 Signaling Pathways Involved in Capecitabine-Induced Hand-Foot Syndrome via Interleukin 6 or Interleukin 8 Abnormal Expression. Chemical Research in Toxicology. 35(3). 422–430. 8 indexed citations

12.

Su, Junwei, et al.. (2022). Survival Outcomes and Safety of Programmed Cell Death/Programmed Cell Death Ligand 1 Inhibitors for Unresectable Hepatocellular Carcinoma: Result From Phase III Trials. Cancer Control. 29. 6 indexed citations

13.

Shi, Yingying, Jiaxin Huang, Yu Liu, et al.. (2022). Structural and biochemical characteristics of mRNA nanoparticles determine anti–SARS-CoV-2 humoral and cellular immune responses. Science Advances. 8(47). eabo1827–eabo1827. 26 indexed citations

14.

Li, Wei, et al.. (2021). Lipocalin-2 Regulates Hippocampal Microglial Activation in Poststroke Depression. Frontiers in Aging Neuroscience. 13. 798335–798335. 19 indexed citations

15.

He, Xiaoying, et al.. (2021). Plasma metabolites, especially lipid metabolites, are altered in pregnant women with gestational diabetes mellitus. Clinica Chimica Acta. 517. 139–148. 23 indexed citations

16.

Liu, Ying, Zhixiao Wang, Jingjing Ren, et al.. (2020). A COVID-19 Risk Assessment Decision Support System for General Practitioners: Design and Development Study. Journal of Medical Internet Research. 22(6). e19786–e19786. 62 indexed citations

17.

Hu, Xingjiang, Hui Yu, Yunliang Zheng, et al.. (2020). Immune Checkpoint Inhibitors and Survival Outcomes in Brain Metastasis: A Time Series-Based Meta-Analysis. Frontiers in Oncology. 10. 564382–564382. 12 indexed citations

18.

Xu, Xiaowei, Xiaoxin Wu, Xiangao Jiang, et al.. (2020). Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series. BMJ. 368. m606–m606. 1497 indexed citations breakdown →

19.

Pan, Hongying, et al.. (2019). Infections Caused by Carbapenemase-Producing Klebsiella pneumoniae : Microbiological Characteristics and Risk Factors. Microbial Drug Resistance. 25(2). 287–296. 25 indexed citations

20.

Qiu, Yunqing, et al.. (2017). " Internet-plus" practice focusing on medical service at tertiary general hospitals. Zhonghua yiyuan guanli zazhi. 33(2). 146–149. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact